Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1

By Kazemi-Esfarjani P.  

Human Molecular Genetics, Vol. 11, Iss. 21, 2002-10 ,pp. : 2657-2672

Oxford University Press

Access to resources Recommend Favorite

Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila

By Nagai Yoshitaka  

Human Molecular Genetics, Vol. 12, Iss. 11, 2003-06 ,pp. : 1253-1259

Oxford University Press

Access to resources Recommend Favorite

Pathogenesis of polyglutamine disorders: aggregation revisited

By Michalik Andrej   Van Broeckhoven Christine  

Human Molecular Genetics, Vol. 12, Iss. 2, 2003-10 ,pp. : 173-186

Oxford University Press

Access to resources Recommend Favorite

Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases

By Branco Joana   Al-Ramahi Ismael   Ukani Lubna   Prez Alma M.   Fernandez-Funez Pedro   Rincn-Limas Diego   Botas Juan  

Human Molecular Genetics, Vol. 17, Iss. 3, 2008-02 ,pp. : 376-390

Oxford University Press

Access to resources Recommend Favorite

The pathogenic agent in Drosophila models of ‘polyglutamine’ diseases

By McLeod Catherine J.   O'Keefe Louise V.   Richards Robert I.  

Human Molecular Genetics, Vol. 14, Iss. 8, 2005-04 ,pp. : 1041-1048

Oxford University Press

Access to resources Recommend Favorite